NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

Background: Easily accessible biomarkers enabling the identification of those patients with multiple sclerosis (MS) who will accumulate irreversible disability in the long term are essential to guide early therapeutic decisions. We here examine the utility of serum neurofilament light chain (sNfL) f...

Full description

Bibliographic Details
Main Authors: Timo Uphaus, Falk Steffen, Muthuraman Muthuraman, Nina Ripfel, Vinzenz Fleischer, Sergiu Groppa, Tobias Ruck, Sven G. Meuth, Refik Pul, Christoph Kleinschnitz, Erik Ellwardt, Julia Loos, Sinah Engel, Frauke Zipp, Stefan Bittner
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EBioMedicine
Subjects:
Multiple sclerosis
Disease progression
Neurofilament light chain
SPMS transition
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003832

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421003832

Similar Items